These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 25234534

  • 41. Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review.
    Javed F, Almas K.
    J Periodontol; 2010 Apr; 81(4):479-84. PubMed ID: 20367090
    [Abstract] [Full Text] [Related]

  • 42. A Strategy against the Osteonecrosis of the Jaw Associated with Nitrogen-Containing Bisphosphonates (N-BPs): Attempts to Replace N-BPs with the Non-N-BP Etidronate.
    Oizumi T, Yamaguchi K, Sato K, Takahashi M, Yoshimura G, Otsuru H, Tsuchiya M, Hagiwara Y, Itoi E, Sugawara S, Takahashi T, Endo Y.
    Biol Pharm Bull; 2016 Apr; 39(9):1549-54. PubMed ID: 27582334
    [Abstract] [Full Text] [Related]

  • 43. Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris.
    Maurer P, Sandulescu T, Kriwalsky MS, Rashad A, Hollstein S, Stricker I, Hölzle F, Kunkel M.
    Int J Oral Maxillofac Surg; 2011 Mar; 40(3):285-91. PubMed ID: 21163624
    [Abstract] [Full Text] [Related]

  • 44. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
    Otto S, Tröltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, Ehrenfeld M, Pautke C.
    J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
    [Abstract] [Full Text] [Related]

  • 45. Database analysis of the risk factors of bisphosphonate-related osteonecrosis of the jaw in Hungarian patients.
    Veszelyné Kotán E, Bartha-Lieb T, Parisek Z, Meskó A, Vaszilkó M, Hankó B.
    BMJ Open; 2019 May 22; 9(5):e025600. PubMed ID: 31122970
    [Abstract] [Full Text] [Related]

  • 46. [Bisphosphonate-related osteonecrosis of the jaw-after a decade has passed].
    Yoneda T.
    Clin Calcium; 2014 Mar 22; 24(3):407-15. PubMed ID: 24576938
    [Abstract] [Full Text] [Related]

  • 47. Risk factors influencing BRONJ staging in patients receiving intravenous bisphosphonates: a multivariate analysis.
    Nisi M, La Ferla F, Karapetsa D, Gennai S, Miccoli M, Baggiani A, Graziani F, Gabriele M.
    Int J Oral Maxillofac Surg; 2015 May 22; 44(5):586-91. PubMed ID: 25701305
    [Abstract] [Full Text] [Related]

  • 48. Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.
    Thumbigere-Math V, Michalowicz BS, Hughes PJ, Basi DL, Tsai ML, Swenson KK, Rockwell L, Gopalakrishnan R.
    J Oral Maxillofac Surg; 2016 Apr 22; 74(4):738-46. PubMed ID: 26501428
    [Abstract] [Full Text] [Related]

  • 49. Bisphosphonate-related osteonecrosis of the jaws: how to manage cancer patients.
    Madrid C, Bouferrache K, Abarca M, Jaques B, Broome M.
    Oral Oncol; 2010 Jun 22; 46(6):468-70. PubMed ID: 20452814
    [Abstract] [Full Text] [Related]

  • 50. Implant Placement Adjacent to Successfully Treated Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).
    Rugani P, Kirnbauer B, Acham S, Truschnegg A, Jakse N.
    J Oral Implantol; 2015 Jul 22; 41 Spec No():377-81. PubMed ID: 24593250
    [No Abstract] [Full Text] [Related]

  • 51. Oral bisphosphonates and dental implants.
    McLeod NM.
    J Oral Maxillofac Surg; 2009 Jun 22; 67(6):1355. PubMed ID: 19446233
    [No Abstract] [Full Text] [Related]

  • 52. Characteristics of the early stages of intravenous bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.
    Matsuo A, Hamada H, Kaise H, Chikazu D, Yamada K, Kohno N.
    Acta Odontol Scand; 2014 Nov 22; 72(8):656-63. PubMed ID: 24521290
    [Abstract] [Full Text] [Related]

  • 53. Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic.
    Nomura T, Shibahara T, Uchiyama T, Yamamoto N, Shibui T, Yakushiji T, Watanabe A, Muramatsu K, Ogane S, Murayama M, Sekine R, Nakata E, Fujimoto Y.
    Bull Tokyo Dent Coll; 2013 Nov 22; 54(2):117-25. PubMed ID: 23903583
    [Abstract] [Full Text] [Related]

  • 54. The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study.
    Dayisoylu EH, Şenel FÇ, Üngör C, Tosun E, Çankaya M, Ersöz S, Taskesen F.
    Int J Oral Maxillofac Surg; 2013 Nov 22; 42(11):1475-80. PubMed ID: 23746422
    [Abstract] [Full Text] [Related]

  • 55. Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw With Plasma Rich in Growth Factors After Dental Implant Surgery: A Case Report.
    Gil IG, Ponte BM, Mateo ST, García JJ.
    J Oral Implantol; 2019 Aug 22; 45(4):289-296. PubMed ID: 31207196
    [Abstract] [Full Text] [Related]

  • 56. Prospective biomarker evaluation in patients with osteonecrosis of the jaw who received bisphosphonates.
    Kim JW, Kong KA, Kim SJ, Choi SK, Cha IH, Kim MR.
    Bone; 2013 Nov 22; 57(1):201-5. PubMed ID: 23954759
    [Abstract] [Full Text] [Related]

  • 57. Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases.
    Hoefert S, Eufinger H.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct 22; 110(4):463-9. PubMed ID: 20692189
    [Abstract] [Full Text] [Related]

  • 58. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G, Manfredi M, Giovannacci I, Mergoni G, Sarraj A, Mureddu M, Giunta G, Bonanini M, Meleti M, Vescovi P.
    Minerva Stomatol; 2017 Aug 22; 66(4):135-140. PubMed ID: 28497661
    [Abstract] [Full Text] [Related]

  • 59. Dental implant placement with bone augmentation in a patient who received intravenous bisphosphonate treatment for osteoporosis.
    Mattheos N, Caldwell P, Petcu EB, Ivanovski S, Reher P.
    J Can Dent Assoc; 2013 Aug 22; 79():d2. PubMed ID: 23763726
    [Abstract] [Full Text] [Related]

  • 60. Osteopathology induced by bisphosphonates and dental implants: clinical observations.
    Jacobsen C, Metzler P, Rössle M, Obwegeser J, Zemann W, Grätz KW.
    Clin Oral Investig; 2013 Jan 22; 17(1):167-75. PubMed ID: 22415216
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.